Opinion: Why It Is Time to Make Conferences Worth It

Very little science from meetings reaches a meaningfully large audience.

Written byNicholas Rowe
| 4 min read
conference meeting scientific presentation poster peer-reviewed publication scholarly journal

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, BRAZZO

Having studied conferences for the last 10 years, I have come to find a disparity in the amount of time and resources scientists put into them and the benefits scientists get out of them as far as transmitting and receiving knowledge. My research shows that conference outputs actually form the numerically dominant medium of global scientific communication, but in terms of disseminating our work to audiences who could use it, their cost and lack of “impact” call into question their sustainability, and urge us to consider how we can better utilize our time, effort, and money.

Conferences are popular events for scientists to meet in person and share results and ideas. Over the last couple of decades, the number of meetings has grown at a rate of roughly 10 percent year over year, and they are clearly not going to go away.

My research has found ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies